BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7758129)

  • 1. Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon-gamma.
    Frandji P; Tkaczyk C; Oskéritzian C; Lapeyre J; Peronet R; David B; Guillet JG; Mécheri S
    Cell Immunol; 1995 Jun; 163(1):37-46. PubMed ID: 7758129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes.
    Frandji P; Tkaczyk C; Oskeritzian C; David B; Desaymard C; Mécheri S
    Eur J Immunol; 1996 Oct; 26(10):2517-28. PubMed ID: 8898968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function.
    Fischer HG; Frosch S; Reske K; Reske-Kunz AB
    J Immunol; 1988 Dec; 141(11):3882-8. PubMed ID: 3141506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-macrophage colony-stimulating factor-cultured bone marrow-derived macrophages reveal accessory cell function and synthesis of MHC class II determinants in the absence of external stimuli.
    Fischer HG; Opel B; Reske K; Reske-Kunz AB
    Eur J Immunol; 1988 Aug; 18(8):1151-8. PubMed ID: 3138135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of differential effects of cytokines on mast cells derived from murine bone marrow and peripheral blood mononuclear cells.
    Rottem M; Hull G; Metcalfe DD
    Exp Hematol; 1994 Nov; 22(12):1147-55. PubMed ID: 7523167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor.
    Falk LA; Wahl LM; Vogel SN
    J Immunol; 1988 Apr; 140(8):2652-60. PubMed ID: 3128601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma.
    Frandji P; Oskéritzian C; Cacaraci F; Lapeyre J; Peronet R; David B; Guillet JG; Mécheri S
    J Immunol; 1993 Dec; 151(11):6318-28. PubMed ID: 8245470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages.
    Zlotnik A; Fischer M; Roehm N; Zipori D
    J Immunol; 1987 Jun; 138(12):4275-9. PubMed ID: 3495588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
    Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
    Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the growth of IL-3-dependent mast cells from murine bone marrow by recombinant granulocyte macrophage-colony-stimulating factor.
    Bressler RB; Thompson HL; Keffer JM; Metcalfe DD
    J Immunol; 1989 Jul; 143(1):135-9. PubMed ID: 2471732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of macrophage activation by IL-3. I. IL-3 functions as a macrophage-activating factor with unique properties, inducing Ia and lymphocyte function-associated antigen-1 but not cytotoxicity.
    Frendl G; Beller DI
    J Immunol; 1990 May; 144(9):3392-9. PubMed ID: 2158509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions.
    Wells JW; Darling D; Farzaneh F; Galea-Lauri J
    Scand J Immunol; 2005 Mar; 61(3):251-9. PubMed ID: 15787742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of interleukin-10 on the expression of HLA class II and CD1 molecules induced by granulocyte/macrophage colony-stimulating factor/interleukin-4.
    Thomssen H; Kahan M; Londei M
    Eur J Immunol; 1995 Sep; 25(9):2465-70. PubMed ID: 7589112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-gamma, and IL-3.
    Gosselin EJ; Wardwell K; Rigby WF; Guyre PM
    J Immunol; 1993 Aug; 151(3):1482-90. PubMed ID: 8335942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells.
    Morrissey PJ; Bressler L; Park LS; Alpert A; Gillis S
    J Immunol; 1987 Aug; 139(4):1113-9. PubMed ID: 3038997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P cell stimulating factor and glucocorticoids oppose the action of interferon-gamma in inducing Ia antigens on T-dependent mast cells (P cells).
    Wong GH; Clark-Lewis I; Hamilton JA; Schrader JW
    J Immunol; 1984 Oct; 133(4):2043-50. PubMed ID: 6088631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UVB-irradiated dendritic cells are impaired in their APC function and tolerize primed Th1 cells but not naive CD4+ T cells.
    Denfeld RW; Hara H; Tesmann JP; Martin S; Simon JC
    J Leukoc Biol; 2001 Apr; 69(4):548-54. PubMed ID: 11310840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell line.
    Derigs HG; Reifel-Miller A; Kaushansky K; Hromas RA; Boswell HS
    Exp Hematol; 1994 Aug; 22(9):924-32. PubMed ID: 8062890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant granulocyte-macrophage colony-stimulating factor restores deficient immune responses in mice with chronic Trypanosoma cruzi infections.
    Reed SG; Grabstein KH; Pihl DL; Morrissey PJ
    J Immunol; 1990 Sep; 145(5):1564-70. PubMed ID: 2117033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.